Diosynvax Ltd.

  • Active
  • Small
  • 8 years
  • 10 employees
  • £2,188,592 (cur assets)
  • 1m-15m
  • Irregular importer
  • Virtual address
  • 7 directors
  • 1 owner
  • Hertford

Field of Operation

Other human health activities
86900 107462 companies

Website

Social media

Summary

Diosynvax Ltd from Hertford UK: small company, active status, founded 7 years ago, 7 employees, £3,653,903 assets, virtual address, 7 directors, 1 owner. Irregular importer of miscellaneous chemical products (2 months imported). It’s a small company as it met two conditions of three: turnover less than £10.2 million, balance sheet less than £5.1 million, employees less than 50. The company operates in the other human health activities industries.

Diosynvax Ltd is a biotechnology company focused on revolutionizing vaccine design. Their website highlights a mission to maximize vaccine protection against viruses, both existing and future, through custom antigen design. They’re patent-protected, combining computational biology with lab and in-vivo validation to select the best vaccine antigen payload candidates. The company partners with leading organizations to advance innovative vaccine solutions, as evidenced by recent collaborations with ACM Biolabs and Innovate UK. News updates showcase progress in developing bird flu vaccines and expanding their advisory board. The site also features a contact section for investors, media, and general inquiries. It's clear they're focused on B2B, selling their expertise and technology rather than directly to consumers.

Financially, Diosynvax Ltd presents a mixed picture. While current assets dropped by a significant 44% to £3.7 million, fixed assets increased by 73% to £460,000. Bank cash fell a substantial 54% to £2.9 million, which is a bit concerning. Creditors decreased by 72%, which is a positive sign of improved debt management, but trade debtors increased by 160%, which could indicate issues with collecting payments. Equity also declined by 66%, which is a worrying trend. The company’s small size helps it remain agile, but the decline in equity and cash reserves suggests it’s burning through money. There's no mention of an auditor, which is common for small companies. The increase in intangible assets, particularly patents, is a good sign, but it's important to see if these translate into revenue. The company’s reliance on a single owner, Heeney Jonathan Luke, could also be a risk factor.

Registered in England/Wales under the registration number 10860446, with a registered address at SG14 1QN, England, Hertford, Janelle House, 6 Hartham Lane.

WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.

Owners & PSC

  • 8 years
  • 2
  • psc

Managers

  • 4 months
  • 1
Secretary
  • 6 years
  • 4
Director
  • 6 years
Director
  • 6 years
Molecular biologist
  • 6 years
Chief operating officer

Last reports

Download the last financial report
Download the last confirmation report
* may contain a full shareholder list

Last news

  1. Registration of charge 108604460001, created on 2026-02-02
  2. Statement of capital following an allotment of shares on 2025-12-24
  3. Appointment of Dr Ian Mcewan as a secretary on 2025-10-09

Importer profile by HS codes

Click on the map to see detailed UK statistics on HS code, including companies list.

Import HS codes in detail

Last imported products

Click on items to see detailed UK statistics on HS code, including companies list.

* Warning: Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.

Similar importers

FAQ about Diosynvax Ltd.

Looking for leads in the UK?

Book a demo—see how CorpSignals can help you find UK leads.

Similar companies